isoproterenol
Conditions | Yield |
---|---|
With water; palladium Hydrogenation; |
isoproterenol
Conditions | Yield |
---|---|
With methanol; palladium Hydrogenation; | |
With methanol; palladium Hydrogenation; |
isoproterenol
5-Cyano-2-methyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid ethyl ester
cyanoacetic acid amide
5-cyano-2-methyl-6-oxo-1,6-dihydro-3-pyridinecarboxylic acid
Conditions | Yield |
---|---|
With sodium hydroxide; N-benzyl-N,N,N-triethylammonium chloride | 90% |
With sodium hydroxide; N-benzyl-N,N,N-triethylammonium chloride | 90% |
methanol
isoproterenol
2-(3,4-dihydroxyphenyl)-2-[(methyl)oxy]-1-(isopropylamino)ethane hydrochloride
Conditions | Yield |
---|---|
With hydrogenchloride for 0.25h; Mechanism; other derivatives of 2-alkylamino-1-(4-hydroxyphenyl)-1-ethanol; | 85% |
With hydrogenchloride for 0.25h; | 85% |
With hydrogenchloride at 10℃; | 85% |
Conditions | Yield |
---|---|
With HNO3; NaOH In water (He); boiling (0.5 h, pH=6.6-6.7), gradual pptn.; washing (distd. water), drying (10E-3 mm Hg, 50°C, 3 h); elem. anal.; | 76% |
isoproterenol
Conditions | Yield |
---|---|
With N,N'-dimethylpiperazine In tetrahydrofuran at 60 - 65℃; for 4h; | 70% |
isoproterenol
Conditions | Yield |
---|---|
With N,N'-dimethylpiperazine In tetrahydrofuran at 50℃; for 4h; | 68% |
Conditions | Yield |
---|---|
With HNO3; NaOH In water boiling (0.5 h, pH=6.6-6.7), gradual pptn.; washing (distd. water), drying (10E-3 mm Hg, 50°C, 3 h); elem. anal.; | 61% |
cis-dichlorobis(triphenylphosphine)platinum(II)
isoproterenol
Pt(P(C6H5)3)2(O2C6H3CH(OH)CH2NHCH(CH3)2)
Conditions | Yield |
---|---|
With potassium hydroxide In methanol; benzene to a suspn. of substituted catechol in benzene was added MeOH soln. of KOH; prepd. soln. was syringed into suspn. of Pt complex in benzene; stirring at room temp. for 3.5 h (Ar); filtration, evapn., washing with water, drying in vac., dissoln. in CH2Cl2, filtration, evapn., washing with ether, drying in vac., crystn. from ether/hexane; elem. anal.; | 50% |
Conditions | Yield |
---|---|
With water; acetic acid; potassium hexacyanoferrate(III) | |
With water; silver(l) oxide | |
With riboflavin In water UV-irradiation; |
Conditions | Yield |
---|---|
With L-Tartaric acid |
Conditions | Yield |
---|---|
With L-Tartaric acid |
Conditions | Yield |
---|---|
mushroom tyrosinase Ambient temperature; phosphate buffer pH=6.8; |
Conditions | Yield |
---|---|
With MCCD-HPS packed column In hydrogenchloride; methanol pH=8.6; | |
With diethylamine In acetonitrile Reagent/catalyst; Resolution of racemate; | |
With phase-transitioned bovine serum albumin film-coated capillary column In methanol pH=9; Resolution of racemate; |
isoproterenol
C11H15NO3
Conditions | Yield |
---|---|
With oxygen In phosphate buffer at 20℃; pH=6.8; Enzyme kinetics; | |
In aq. phosphate buffer pH=5; pH-value; Concentration; Electrochemical reaction; |
isoproterenol
N-isopropyl-5,6-diacetoxyindole
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: Mushroom tyrosinase / Ambient temperature; phosphate buffer pH=6.8 2: 1) ascorbic acid, 2) dimethylaminopyridine / 2) Phosphate buffer, diethyl ether, 2) diethyl ether View Scheme |
isoproterenol
Divascan
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: silver oxide; water View Scheme | |
Multi-step reaction with 2 steps 1: potassium hexacyanoferrate(III); water; acetic acid View Scheme |
isoproterenol
Conditions | Yield |
---|---|
In not given reflux of soln. of metal salt and ligand in 1:2 molar ratio (slight excess of ligand) for 5 h; concd. on water bath, vac. drying in vac. desiccator, washing with abs.alc., alc. soln. dried in vac., elem. anal.; |
Conditions | Yield |
---|---|
In not given reflux of soln. of metal salt and ligand in 1:2 molar ratio (slight excess of ligand) for 5 h; concd. on water bath, vac. drying in vac. desiccator, washing with abs.alc., alc. soln. dried in vac., elem. anal.; |
isoproterenol
Conditions | Yield |
---|---|
In not given reflux of soln. of metal salt and ligand in 1:2 molar ratio (slight excess of ligand) for 5 h; concd. on water bath, vac. drying in vac. desiccator, washing with abs.alc., alc. soln. dried in vac., elem. anal.; |
isoproterenol
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: HNO3; NaOH / water 2: H2O / neat (no solvent, solid phase) View Scheme |
Molecular Formula: C11H17NO3
Molecular Weight: 211.26
EINECS: 231-687-7
Density: 1.199 g/cm3
Flash Point: 179.7 °C
Melting Point: 155.5°C
Index of Refraction: 1.579
Appearance: Off-color crystal
CAS Registry Number: 7683-59-2
Enthalpy of Vaporization: 70.73 kJ/mol
Boiling Point: 417.5 °C at 760 mmHg
Vapour Pressure: 1.02E-07 mmHg at 25°C
IUPAC Name: 4-[1-Hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol
Synonyms: 4-[1-Hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol ; Isoproterenol ; Isoprel ; Isoprenaline ; Saventrine ; 1,2-Benzenediol, 4-1-hydroxy-2-(1-methylethyl)aminoethyl- ; 1,2-Benzenediol, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]- (9CI) ; Dl-Isadrine
Following is the molecular structure of Isoproterenol (CAS NO.7683-59-2)
Isoproterenol (CAS NO.7683-59-2)'s primary use is for bradycardia or heart block. By activating β1-receptors on the heart, it induces positive chronotropic, dromotropic, and inotropic effects.
It can be used as an inhaled aerosol to treat asthma, although this is currently a rare treatment.[1] Although it activates all beta adrenergic receptors, it works in a similar fashion to the more selective β2-adrenergic agonists e.g. salbutamol, by relaxing the airways to increase airflow.
It is also supplied in ampules under the brand name Isuprel for injection and in sublingual pill form for treatment of asthma, chronic bronchitis and emphysema.
Used with caution, Isoproterenol (CAS NO.7683-59-2) can also be used to treat torsades de pointes by congenital defect, in conjunction with overdrive pacing and magnesium.
Adipose tissue also has β-receptors that can be activated by isoproterenol. Once activated, adipocytes begin breaking down the fat stored inside them. This has caused isoproterenol to be used off-label in mesotherapy for body contouring and to help decrease fat. Two studies showed that it can cause a decrease in thigh size.
1. | oms-rat-par 100 mg/kg | BEXBAN Bulletin of Experimental Biology and Medicine. Translation of BEBMAE. 94 (1982),1458. | ||
2. | dns-mus-ipr 341 mg/kg | JCLBA3 Journal of Cell Biology. 56 (1973),605. | ||
3. | ims-hmn TDLo:14 µg/kg:CVS | KLWOAZ Klinische Wochenscrift. 19 (1940),1303. | ||
4. | orl-rat LD50:355 mg/kg | USXXAM United States Patent Document. (Commissioner of Patents and Trademarks, Washington, DC 20231) #4026897 . | ||
5. | ipr-rat LDLo:100 mg/kg | FCTXAV Food and Cosmetics Toxicology. 3 (1965),597. | ||
6. | scu-rat LD50:600 µg/kg | TOXID9 Toxicologist. 4 (1984),77. | ||
7. | ivn-rat LD50:57 mg/kg | TXAPA9 Toxicology and Applied Pharmacology. 16 (1970),303. | ||
8. | orl-mus LD50:450 mg/kg | 27ZIAQ Drug Dosages in Laboratory Animals-A Handbook C.D. Barnes andL.G. Eltherington,Berkeley, CA.: Univ. of California Press,1973,139. | ||
9. | ipr-mus LD50:440 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 164 (1968),290. | ||
10. | scu-mus LD50:400 mg/kg | ARZNAD Arznei |
Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. An experimental teratogen. Other experimental reproductive effects. Human systemic effects by intramuscular route: increased pulse and cardiac rate. A bronchodilator. Mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View